Form 8-K - Current report:
SEC Accession No. 0001477932-25-001476
Filing Date
2025-03-05
Accepted
2025-03-04 18:03:09
Documents
15
Period of Report
2025-03-03
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K upxi_8k.htm   iXBRL 8-K 24081
  Complete submission text file 0001477932-25-001476.txt   140798

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA upxi-20250303.xsd EX-101.SCH 5874
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE upxi-20250303_lab.xml EX-101.LAB 13717
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE upxi-20250303_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE upxi-20250303_pre.xml EX-101.PRE 8614
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE upxi-20250303_def.xml EX-101.DEF 2099
17 EXTRACTED XBRL INSTANCE DOCUMENT upxi_8k_htm.xml XML 3656
Mailing Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607
Business Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607 701-353-5425
UPEXI, INC. (Filer) CIK: 0001775194 (see all company filings)

EIN.: 833378978 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-40535 | Film No.: 25707130
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)